Clinical Trials Directory

Trials / Completed

CompletedNCT00868712

Warfarin and Coronary Calcification Project

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Walter Reed Army Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess whether the use of warfarin, a commonly used anticoagulation drug, is associated with increased amounts of coronary artery calcification. Studies in animals and preliminary but small retrospective studies in humans have suggested a possible link to increased tissue calcification with use of this drug. The researchers will investigate this by assessing the amount of calcification seen in the coronary arteries using a specialized computed tomography (CT) scan (electron-beam CT) and assessing to see if the amount is influenced by the amount of time a patient has been taking warfarin. The researchers will exclude patients with known coronary artery disease, chronic kidney disease or hyperparathyroidism.

Conditions

Timeline

Start date
2004-05-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2009-03-25
Last updated
2012-08-24
Results posted
2012-08-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00868712. Inclusion in this directory is not an endorsement.